These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9544338)

  • 21. [Neurocysticercosis and convulsive crises].
    Fernández-Gómez JM; García-Garmendia JL; López-Domínguez JM; Casado-Chocán JL
    Rev Neurol; 1998 Jun; 26(154):1072-3. PubMed ID: 9658497
    [No Abstract]   [Full Text] [Related]  

  • 22. Praziquantel vs. albendazol for cysticercosis.
    Quintero-Rodriguez E
    Neurosurgery; 1988 Jul; 23(1):128. PubMed ID: 3173656
    [No Abstract]   [Full Text] [Related]  

  • 23. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
    Romo ML; Carpio A; Kelvin EA
    J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.
    García HH; Del Brutto OH
    Neurology; 1999 Oct; 53(7):1582-4. PubMed ID: 10534273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis].
    Cohen L; Belec L; Sanson M; Pierrot-Deseilligny C; Signoret JL
    Rev Neurol (Paris); 1992; 148(1):58-61. PubMed ID: 1604116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysticercosis and epilepsy: a critical review.
    Carpio A; Escobar A; Hauser WA
    Epilepsia; 1998 Oct; 39(10):1025-40. PubMed ID: 9776322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis.
    Jung H; Hurtado M; Sanchez M; Medina MT; Sotelo J
    Clin Neuropharmacol; 1990 Dec; 13(6):559-64. PubMed ID: 2276121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controversies in the management of cysticercosis.
    Evans C; Garcia HH; Gilman RH; Friedland JS
    Emerg Infect Dis; 1997; 3(3):403-5. PubMed ID: 9284392
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller].
    Epelboin L; Klement E; Chemali N; Danis M; Bricaire E; Caumes E
    Bull Soc Pathol Exot; 2004 Nov; 97(4):250-2. PubMed ID: 17304744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
    Francisca PA; Javier LF; Guadalupe PH; Fernanda GM; Nelly C; Helgi JC; Iliana GH; Susana RI
    Acta Trop; 2020 Feb; 202():105238. PubMed ID: 31669532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taeniasis and cysticercosis.
    Cook GC
    J R Soc Med; 1998 Oct; 91(10):534-5. PubMed ID: 10070374
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comments about the article on taeniasis and cysticercosis caused by Taenia solium].
    López Antuñano FJ
    Salud Publica Mex; 2000; 42(1):1-2. PubMed ID: 10743389
    [No Abstract]   [Full Text] [Related]  

  • 34. Albendazole therapy for neurocysticercosis.
    Escobedo F; Penagos P; Rodriguez J; Sotelo J
    Arch Intern Med; 1987 Apr; 147(4):738-41. PubMed ID: 3827462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albendazole in neurocysticercosis.
    Padma MV; Behari M; Misra NK; Ahuja GK
    Natl Med J India; 1995; 8(6):255-8. PubMed ID: 8520442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prolonged treatment of recurrent neurocysticercosis using sequential doses of albendazole and praziquantel].
    Chagnon A; Galzin M; de Jaureguiberry JP; Boyer B; Paris JF; Marlier S; Carli P
    Med Trop (Mars); 1994; 54(3):275-6. PubMed ID: 7885211
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel.
    Takayanagui OM; Jardim E
    Arch Neurol; 1992 Mar; 49(3):290-4. PubMed ID: 1536632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci.
    Fraga CM; Costa TL; Bezerra JC; de Souza Lino R; Vinaud MC
    Exp Parasitol; 2012 Feb; 130(2):146-51. PubMed ID: 22127328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocysticercosis.
    Mehndiratta MM; Gupta M
    J Assoc Physicians India; 1990 Nov; 38(11):879-80. PubMed ID: 2079487
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of brain cysticercosis.
    Sotelo J
    Surg Neurol; 1997 Aug; 48(2):110-2. PubMed ID: 9242234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.